{"name":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","slug":"fundaci-n-p-blica-andaluza-para-la-investigaci-n-de-m-laga-en-biomedicina-y-salu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"Humalog Kwikpen","genericName":"Humalog Kwikpen","slug":"humalog-kwikpen","indication":"Type 1 diabetes mellitus","status":"marketed"},{"name":"Metformin + Testosterone Undecanoate","genericName":"Metformin + Testosterone Undecanoate","slug":"metformin-testosterone-undecanoate","indication":"Type 2 diabetes with hypogonadism","status":"phase_3"},{"name":"Toujeo SoloStar","genericName":"Toujeo SoloStar","slug":"toujeo-solostar","indication":"Type 1 diabetes mellitus","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Prednisone withdrawal","genericName":"Prednisone withdrawal","slug":"prednisone-withdrawal","indication":"Other","status":"marketed"},{"name":"Experimental: RAL QD","genericName":"Experimental: RAL QD","slug":"experimental-ral-qd","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Active comparator: DRV/cb","genericName":"Active comparator: DRV/cb","slug":"active-comparator-drv-cb","indication":"HIV-1 infection in treatment-experienced and treatment-naïve adults","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Prednisone continuation","genericName":"Prednisone continuation","slug":"prednisone-continuation","indication":"Inflammatory and autoimmune disorders","status":"marketed"}]}],"pipeline":[{"name":"Prednisone withdrawal","genericName":"Prednisone withdrawal","slug":"prednisone-withdrawal","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Active comparator: DRV/cb","genericName":"Active comparator: DRV/cb","slug":"active-comparator-drv-cb","phase":"marketed","mechanism":"DRV/c (darunavir boosted with cobicistat) is a protease inhibitor combined with a pharmacokinetic booster that blocks HIV protease to prevent viral replication.","indications":["HIV-1 infection in treatment-experienced and treatment-naïve adults","HIV-1 infection in combination antiretroviral therapy"],"catalyst":""},{"name":"Experimental: RAL QD","genericName":"Experimental: RAL QD","slug":"experimental-ral-qd","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Humalog Kwikpen","genericName":"Humalog Kwikpen","slug":"humalog-kwikpen","phase":"marketed","mechanism":"Humalog is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in cells.","indications":["Type 1 diabetes mellitus","Type 2 diabetes mellitus"],"catalyst":""},{"name":"Metformin + Testosterone Undecanoate","genericName":"Metformin + Testosterone Undecanoate","slug":"metformin-testosterone-undecanoate","phase":"phase_3","mechanism":"Metformin improves insulin sensitivity and glucose metabolism while testosterone undecanoate restores androgen levels, together addressing metabolic dysfunction and hypogonadism.","indications":["Type 2 diabetes with hypogonadism","Metabolic syndrome with testosterone deficiency"],"catalyst":""},{"name":"Prednisone continuation","genericName":"Prednisone continuation","slug":"prednisone-continuation","phase":"marketed","mechanism":"Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors.","indications":["Inflammatory and autoimmune disorders","Allergic reactions","Certain malignancies (as adjunctive therapy)","Adrenal insufficiency","Respiratory conditions with inflammation"],"catalyst":""},{"name":"Toujeo SoloStar","genericName":"Toujeo SoloStar","slug":"toujeo-solostar","phase":"marketed","mechanism":"Toujeo SoloStar is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake and storage in cells.","indications":["Type 1 diabetes mellitus","Type 2 diabetes mellitus"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":7,"phaseCounts":{"marketed":6,"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}